HARMONY BIOSCIENCES HOLDINGS
HRMYNASDAQπ #1848 by market capUS Equity
ββ
Quote unavailableTrack HRMY
Get earnings, price moves & breaking news on Telegram
24hβ
7dβ
14dβ
30dβ
ytdβ
1yβ
π¦Market Cap
$1.91B
Small Cap
πRevenue Growth (YoY)
19.8%
Healthy
πGross Margin
74.0%
High
π΅FCF Margin
30.7%
Strong
βοΈP/S Ratio
1.9x
Cheap
Otter Score
76
Strong
No chart data available for HRMY.
Trading Snapshot
- Day Range
- β
- 52-Week Range
- $25.90 β $43.49
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 58.2M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $868M
- Last Q Revenue
- $269M
- P/E Ratio
- 10.7
- P/S Ratio
- 1.9x
- EPS (TTM)
- $3.03
- Dividend Yield
- β
- Dilution (1yr)
- +0.8%
HARMONY BIOSCIENCES HOLDINGS
HRMYFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$868Mβ² +21.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
77.2%βΌ β1.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
$208Mβ² +9.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$348Mβ² +59.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
58.7Mβ² +0.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$513Mβ² +$241M YoY
About HARMONY BIOSCIENCES HOLDINGS
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Strong
76/100
Analyst data unavailable.
Latest News & Updates
News unavailable.